Baldassarre Stea Selected Research

ErbB-2 Receptor

7/2006

c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baldassarre Stea Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 02/2004
10	Brain Neoplasms (Brain Tumor) 01/2022 - 06/2003
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2006
5	Breast Neoplasms (Breast Cancer) 11/2009 - 09/2002
4	Melanoma (Melanoma, Malignant) 12/2017 - 01/2010
4	Glioblastoma (Glioblastoma Multiforme) 12/2009 - 12/2003
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 10/2018
3	Skin Neoplasms (Skin Cancer) 12/2017 - 10/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2013 - 09/2005
3	Hypoxia (Hypoxemia) 10/2012 - 09/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 05/2019
2	Fatigue 01/2020 - 09/2005
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 10/2018
2	Disease Progression 10/2019 - 01/2017
2	Glioma (Gliomas) 08/2016 - 04/2006
1	Hyperthermia 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Leukemia 10/2018
1	Scleredema Adultorum 01/2016
1	Uveal melanoma 09/2015
1	Exanthema (Rash) 03/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2012
1	Orbital lymphoma 01/2009
1	Cataract (Cataracts) 01/2009
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2008
1	Lymphoma (Lymphomas) 05/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2008
1	Radiation Pneumonitis 09/2005
1	Retinoblastoma (Glioblastoma, Retinal) 02/2004
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2004
1	Squamous Cell Carcinoma of Head and Neck 02/2004
1	Carcinogenesis 02/2004
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2003
1	Radiodermatitis 01/2002

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 10/2012 - 09/2002
5	efaproxiral (RSR-13)IBA 12/2007 - 06/2003
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 05/2008
3	Hemoglobins (Hemoglobin)IBA 12/2007 - 01/2006
2	Bendamustine Hydrochloride FDA Link 01/2020 - 10/2018
2	ErbB Receptors (EGF Receptor)IBA 10/2012 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 11/2009 - 07/2009
2	EnzymesIBA 07/2009 - 07/2006
2	iotrexIBA 07/2008 - 04/2006
2	Oxygen (Dioxygen)IBA 03/2006 - 01/2006
1	Busulfan (Busulfex)FDA Link 01/2020
1	fludarabineIBA 01/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	Melphalan (Alkeran)FDA LinkGeneric 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	pembrolizumabIBA 10/2019
1	IpilimumabIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 08/2016
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 08/2016
1	Iodine-125IBA 09/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2013
1	Biomarkers (Surrogate Marker)IBA 10/2012
1	Proto-Oncogene Proteins c-metIBA 12/2009
1	amuvatinibIBA 12/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2009
1	DNA (Deoxyribonucleic Acid)IBA 07/2009
1	Rad51 RecombinaseIBA 07/2009
1	Rituximab (Mabthera)FDA Link 05/2008
1	Vincristine (Oncovin)FDA LinkGeneric 05/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2008
1	Prednisone (Sone)FDA LinkGeneric 05/2008
1	ErbB-2 ReceptorIBA 07/2006
1	Hormones (Hormone)IBA 07/2006
1	Radiation-Sensitizing AgentsIBA 01/2006
1	Histidine (L-Histidine)FDA Link 02/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2004
1	Tyrosine Kinase InhibitorsIBA 12/2003
1	Gefitinib (Iressa)FDA Link 12/2003
1	ParaffinIBA 09/2002
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 09/2002
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2002
1	Formaldehyde (Formol)FDA Link 09/2002
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2002

Therapy/Procedure

26	Radiotherapy 01/2022 - 01/2003
7	Brachytherapy 12/2017 - 04/2006
5	Therapeutics 01/2022 - 12/2009
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 10/2018
3	Drug Therapy (Chemotherapy) 12/2017 - 01/2010
2	Transplantation 01/2022 - 01/2020
2	Immunotherapy 01/2022 - 01/2017
2	Catheters 07/2008 - 04/2006
1	Cryosurgery 01/2022
1	Radiofrequency Ablation 01/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Hematopoietic Stem Cell Transplantation 05/2019
1	Cell Transplantation 05/2019
1	Drug Tapering 03/2013
1	Adjuvant Chemotherapy 01/2010
1	Lenses 01/2009
1	Re-Irradiation 04/2006
1	Induction Chemotherapy 09/2005